The latest closing stock price for Fate Therapeutics as of January 31, 2025 is 1.30.
An investor who bought $1,000 worth of Fate Therapeutics stock at the IPO in 2013 would have $-804 today, roughly -1 times their original investment - a -13.75% compound annual growth rate over 11 years.
The all-time high Fate Therapeutics stock closing price was 117.40 on January 14, 2021.
The Fate Therapeutics 52-week high stock price is 8.83, which is 579.2% above the current share price.
The Fate Therapeutics 52-week low stock price is 1.04, which is 20% below the current share price.
The average Fate Therapeutics stock price for the last 52 weeks is 3.95.
An investor who bought $1,000 worth of Fate Therapeutics stock at the IPO in 2013 would have $-804 today, roughly -1 times their original investment - a -13.75% compound annual growth rate over 11 years.
The all-time high Fate Therapeutics stock closing price was 117.40 on January 14, 2021.
The Fate Therapeutics 52-week high stock price is 8.83, which is 579.2% above the current share price.
The Fate Therapeutics 52-week low stock price is 1.04, which is 20% below the current share price.
The average Fate Therapeutics stock price for the last 52 weeks is 3.95.